Vor-Wordmark-RGB-FullColor-070920.png
Vor Bio to Participate in the Oppenheimer's 35th Annual Healthcare Life Sciences Conference
February 03, 2025 08:00 ET | Vor Biopharma
CAMBRIDGE, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host...
Hematology Diagnostics Market
Hematology Diagnostics Industry Forecast to Grow from $4.06 Billion in 2024 to $5.93 Billion by 2030 - Abbott, Beckman Coulter, Sysmex Corp, Roche, and Siemens Healthineers Lead the Competition
January 21, 2025 04:05 ET | Research and Markets
Dublin, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The "Hematology Diagnostics Market Size, Share & Trends Analysis by Product, Test, End Use, and Region, 2025-2030" report has been added to ...
Global Leukapheresis Market
Leukapheresis Market Outlook Report 2025: Leukapheresis Market Projected to Surge to USD 672.4 Million by 2034, Driven by Technological Advances and Rising Demand for Blood Cancers Treatment
January 07, 2025 08:45 ET | Research and Markets
Dublin, Jan. 07, 2025 (GLOBE NEWSWIRE) -- The "Leukapheresis Market by Product, by Application, by End-User, and By Region" report has been added to ResearchAndMarkets.com's offering.The global...
Vor-Wordmark-RGB-FullColor-070920.png
Vor Bio Announces $55.6 Million Private Placement
December 27, 2024 09:00 ET | Vor Biopharma
Intend to announce updated clinical data from Phase 1/2 VBP301 trial of VCAR33ALLO in the first half of 2025 and updated clinical data from Phase 1/2a VBP101 trial of trem-cel in combination with...
Vor-Wordmark-RGB-FullColor-070920.png
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design
December 09, 2024 07:30 ET | Vor Biopharma
Preliminary data suggests improved relapse-free survival compared to published groups of acute myeloid leukemia (AML) patients at high risk of relapse post-transplantTrem-cel + Mylotarg continue to...
Skyquest Logo
Cancer Monoclonal Antibodies Market to Grow at a 18.4% CAGR through 2031 | SkyQuest Technology
December 09, 2024 07:10 ET | SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, Dec. 09, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the cancer monoclonal antibodies market size will attain a value of USD 337.92 billion by 2031, with a CAGR of 18.4% over the...
Smart Immune et CELL
Smart Immune et CELLforCURE by SEQENS s'associent pour industrialiser la production des lots cliniques de SMART101
December 03, 2024 00:00 ET | Smart Immune
COMMUNIQUÉ DE PRESSE | Paris, France - 3 décembre 2024 Smart Immune, société de biotechnologie en stade clinique, et CELLforCURE by SEQENS, entreprise de développement et de fabrication en...
Smart Immune and CEL
Smart Immune and CELLforCURE by SEQENS Partner to Industrialize SMART101 Clinical Batches Manufacturing
December 03, 2024 00:00 ET | Smart Immune
PRESS RELEASE | Paris, France – December 3, 2024 Smart Immune, a clinical-stage biotechnology company, and CELLforCURE by SEQENS, a Contract Development and Manufacturing Organization (CDMO) for...
Carlos Chattah Photography
9-Year Old Rare Blood Disorder Survivor Meets Lifesaving Donor at Gift of Life Marrow Registry Gala
November 22, 2024 15:37 ET | Gift of Life Marrow Registry
Miami Beach Event Honored Emilio Estefan, Jr., Vice Mayor Alex Fernandez and Boucher Brothers for their Distinguished Advocacy BOCA RATON, Fla., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Gift of Life...
Vor-Wordmark-RGB-FullColor-070920.png
Vor Bio to Participate in the Stifel 2024 Healthcare Conference
November 12, 2024 08:00 ET | Vor Biopharma
CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host...